
EZZ Life Science Holdings Limited
ASX:EZZ.AX
2.46 (AUD) • At close July 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 30.288 | 44.747 | 21.697 | 22.018 | 15.126 | 8.808 | 6.214 | 9.723 | 12.565 | 8.248 | 9.067 | 5.594 | 5.594 |
Cost of Revenue
| 6.979 | 10.013 | 7.14 | 5.336 | 4.605 | 4.829 | 3.699 | 5.009 | 5.627 | 6.444 | 7.31 | 3.413 | 3.413 |
Gross Profit
| 23.309 | 34.734 | 14.557 | 16.682 | 10.521 | 3.979 | 2.515 | 4.713 | 6.938 | 1.804 | 1.758 | 2.18 | 2.18 |
Gross Profit Ratio
| 0.77 | 0.776 | 0.671 | 0.758 | 0.696 | 0.452 | 0.405 | 0.485 | 0.552 | 0.219 | 0.194 | 0.39 | 0.39 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 1.205 | 0.117 | 0.059 | 0.049 | 0.071 | 0.06 | 0.079 | 0.068 | 0.01 | 0.074 | 0.074 | 0.45 | 0.45 |
Selling & Marketing Expenses
| 16.317 | 25.496 | 5.867 | 6.399 | 3.88 | 0.864 | 0.621 | 1.585 | 2.337 | 0.273 | 0.504 | 0.985 | 0.985 |
SG&A
| 17.522 | 26.511 | 13.064 | 13.82 | 8.767 | 2.348 | 2.504 | 3.688 | 5.39 | 0.862 | 1.22 | 1.592 | 1.592 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 17.522 | 26.511 | 13.064 | 13.82 | 8.767 | 2.348 | 2.504 | 3.688 | 5.39 | 0.862 | 1.22 | 1.592 | 1.592 |
Operating Income
| 5.787 | 8.223 | 1.493 | 2.862 | 1.754 | 1.631 | 0.011 | 1.025 | 1.548 | 0.943 | 0.537 | 0.589 | 0.589 |
Operating Income Ratio
| 0.191 | 0.184 | 0.069 | 0.13 | 0.116 | 0.185 | 0.002 | 0.105 | 0.123 | 0.114 | 0.059 | 0.105 | 0.105 |
Total Other Income Expenses Net
| -1.028 | 0.21 | 0.033 | 0.261 | 0.025 | 0.033 | 0.104 | 0.03 | 0.134 | 0.674 | -0.004 | 0 | 0 |
Income Before Tax
| 4.759 | 8.433 | 1.526 | 3.122 | 1.778 | 1.664 | 0.116 | 1.055 | 1.682 | 1.617 | 0.533 | 0.589 | 0.589 |
Income Before Tax Ratio
| 0.157 | 0.188 | 0.07 | 0.142 | 0.118 | 0.189 | 0.019 | 0.108 | 0.134 | 0.196 | 0.059 | 0.105 | 0.105 |
Income Tax Expense
| 1.561 | 2.611 | 0.384 | 0.792 | 0.479 | 0.451 | 0.016 | 0.247 | 0.459 | 0.403 | 0.161 | 0.177 | 0.177 |
Net Income
| 3.198 | 5.822 | 1.142 | 2.331 | 1.299 | 1.213 | 0.1 | 0.808 | 1.223 | 1.214 | 0.372 | 0.412 | 0.412 |
Net Income Ratio
| 0.106 | 0.13 | 0.053 | 0.106 | 0.086 | 0.138 | 0.016 | 0.083 | 0.097 | 0.147 | 0.041 | 0.074 | 0.074 |
EPS
| 0.071 | 0.13 | 0.027 | 0.055 | 0.03 | 0.029 | 0.002 | 0.019 | 0.029 | 0.029 | 0.009 | 0.01 | 0.01 |
EPS Diluted
| 0.071 | 0.13 | 0.027 | 0.055 | 0.03 | 0.029 | 0.002 | 0.019 | 0.029 | 0.029 | 0.009 | 0.01 | 0.01 |
EBITDA
| 4.806 | 8.644 | 1.732 | 3.254 | 1.839 | 1.726 | 0.176 | 1.124 | 1.75 | 1.016 | 0.611 | 0.59 | 0.59 |
EBITDA Ratio
| 0.159 | 0.193 | 0.08 | 0.148 | 0.122 | 0.196 | 0.028 | 0.116 | 0.139 | 0.123 | 0.067 | 0.106 | 0.106 |